Shinsuke Nakao
Inventor
Stats
- 1 US patents issued
- 7 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 7 US Applications Filed
- 35 Total Citation Count
- Aug 27, 2020 Most Recent Filing
- Apr 26, 1999 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| ASTELLAS PHARMA INC. | 1
1 | 2014
2017 |
| FANUC LTD | 1
| 1999
|
| NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY | 1
| 2017
|
Inventor Addresses
| Address | Duration |
|---|---|
| Chuo-ku, Tokyo, JP | Oct 14, 21 - Oct 14, 21 |
| Oshino-mura, JP | Dec 12, 00 - Dec 12, 00 |
| Tokyo, JP | Nov 03, 16 - Sep 15, 22 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 4 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
| C07K: | PEPTIDES | 4 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2022/0290,179 | 2022 | GENETICALLY ENGINEERED ONCOLYTIC VACCINIA VIRUSES AND METHODS OF USES THEREOF | 0 |
| 2021/0315,951 | 2021 | CANCER THERAPY BY COMBINATION USE OF ONCOLYTIC VACCINIA VIRUS AND IMMUNE CHECKPOINT INHIBITOR, AND PHARMACEUTICAL COMPOSITION AND COMBINATION MEDICINE FOR USE IN THE CANCER THERAPY | 0 |
| 11046770 | 2021 | Anti-human BDCA-2 antibody | 0 |
| 10888594 | 2021 | Genetically engineered vaccinia viruses | 1 |
| 10849946 | 2020 | Genetically engineered vaccinia viruses | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.